This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Capitalbio Corporation, Tsinghua University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022
Title: Zhengde Feng: Innovator in Microfluidic Technology
Introduction
Zhengde Feng is a prominent inventor based in Beijing, China. He is known for his contributions to the field of microfluidics, particularly in the development of integrated devices for nucleic acid amplification and detection. His innovative work has the potential to significantly advance diagnostic technologies.
Latest Patents
Zhengde Feng holds a patent for an "Integrated microfluidic device for target amplification and microarray detection." This device is designed to facilitate nucleic acid amplification and microarray detection in a closed system. It features a microchip with multiple reservoirs, channels, and valves, along with an amplification chamber for PCR and a microarray chamber for hybridization detection. This integrated approach addresses contamination issues during amplification and hybridization reactions, showcasing his commitment to improving laboratory processes.
Career Highlights
Throughout his career, Zhengde Feng has worked with notable organizations, including Capitalbio Corporation and Tsinghua University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in microfluidic technology.
Collaborations
Zhengde Feng has collaborated with talented individuals such as Yang Wang and Guohao Zhang. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Zhengde Feng's work in microfluidic technology exemplifies the impact of innovative thinking in scientific research. His contributions continue to pave the way for advancements in diagnostic applications, making him a noteworthy figure in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile